Smith & Nephew has announced it has revised plans to leave Hull after almost 170 years in the city, citing an increase in ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) ...

Smith & Nephew (LSE:SN.) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights ...

Smith+Nephew (NYSE: SNN) announced today that it launched its Legion hinged knee (HK) system with Oxinium implant technology ...

The medical company announced in 2022 that it was leaving the city but now says it plans to operate in both Hull and Melton ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) System is now available in the United States with proprietary OXINIUM ...

Smith & Nephew (LSE:SN.) is navigating a dynamic period marked by both opportunities and challenges. Recent highlights include a notable 31.2% increase in dividend payouts and innovative product ...

Smith+Nephew designed Catalystem to meet new primary hip surgery needs, including the increased adoption of anterior approach ...

The "Global Wound Care Market: Analysis By Product, By Application, By Mode of Purchase, By End User, By Region Size and Trends and Forecast up to 2029" report has been added to ResearchAndMarkets.com ...

First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility GlobeNewswire September 18, 2024 Smith+Nephew (LSE:SN, NYSE:SNN), ...

LONDON (Alliance News) - Smith & Nephew PLC on Thursday reconfirmed its annual guidance and said revenue increased in the third quarter of the year due to strong performances from its ...